Miriam Shellabear is a Precision Medicine Investigator at GSK, where they manage projects across multiple therapy areas including Oncology and Cardiovascular, Renal, and Metabolic (CVRM). With a strong background in clinical trial management, they have received recognition for their contributions to innovative projects, notably earning an AstraZeneca Global Award for their work on the Evushield program. Miriam’s experience encompasses roles as a Clinical Lab Technician at Illumina, a DNA Analyst at LGC, and a Forensic Intelligence Officer with West Yorkshire Police. They hold a Master's degree in Forensic and Conservation Genetics and have completed various leadership and project management qualifications.
This person is not in any teams
This person is not in any offices